SZSE:003017 (China)
Â
Class A
Â¥
20.67
(+3.56%)
Nov 29
Business Description
Zhejiang Dayang Biotech Group Co Ltd
ISIN : CNE100004736
Share Class Description:
SZSE:003017: Class ACompare
Compare
Traded in other countries / regions
003017.China IPO Date
2020-10-26Description
Zhejiang Dayang Biotech Group Co Ltd is engaged in production and sales of chemical raw materials such as inorganic salts and veterinary raw materials. The company produces three core industries of potassium salt, veterinary drug and fluorine chemicals. Along with potassium carbonate, potassium bicarbonate and ammonium chloride products, it forms the product group of food additive grade, industrial grade, agricultural grade.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.11 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.33 | |||||
| Debt-to-EBITDA | 4.8 | |||||
| Interest Coverage | 9.98 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.76 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.7 | |||||
| 3-Year EBITDA Growth Rate | -8.6 | |||||
| 3-Year EPS without NRI Growth Rate | -17.8 | |||||
| 3-Year Book Growth Rate | 1.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.61 | |||||
| 9-Day RSI | 68.87 | |||||
| 14-Day RSI | 65.42 | |||||
| 6-1 Month Momentum % | 3.84 | |||||
| 12-1 Month Momentum % | -17.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 0.97 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 74.78 | |||||
| Days Sales Outstanding | 26.67 | |||||
| Days Payable | 86.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.11 | |||||
| Dividend Payout Ratio | 0.99 | |||||
| Forward Dividend Yield % | 4.11 | |||||
| 5-Year Yield-on-Cost % | 4.11 | |||||
| Shareholder Yield % | 7.35 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 20.03 | |||||
| Operating Margin % | 9.43 | |||||
| Net Margin % | 6.97 | |||||
| FCF Margin % | 7.97 | |||||
| ROE % | 6.06 | |||||
| ROA % | 3.9 | |||||
| ROIC % | 7.06 | |||||
| ROC (Joel Greenblatt) % | 10.41 | |||||
| ROCE % | 6.41 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.6 | |||||
| PE Ratio without NRI | 24.15 | |||||
| PS Ratio | 1.94 | |||||
| PB Ratio | 1.69 | |||||
| Price-to-Tangible-Book | 1.85 | |||||
| Price-to-Free-Cash-Flow | 23.35 | |||||
| Price-to-Operating-Cash-Flow | 9.84 | |||||
| EV-to-EBIT | 23.19 | |||||
| EV-to-EBITDA | 23.19 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-FCF | 22.12 | |||||
| Price-to-Projected-FCF | 2.44 | |||||
| Price-to-Graham-Number | 1.41 | |||||
| Price-to-Net-Current-Asset-Value | 21.09 | |||||
| Earnings Yield (Greenblatt) % | 4.31 | |||||
| FCF Yield % | 4.02 | |||||
| Forward Rate of Return (Yacktman) % | -5.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Dayang Biotech Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 876.503 | ||
| EPS (TTM) (Â¥) | 0.749 | ||
| Beta | 1.03 | ||
| Volatility % | 36.37 | ||
| 14-Day RSI | 65.42 | ||
| 14-Day ATR (Â¥) | 0.784404 | ||
| 20-Day SMA (Â¥) | 19.496 | ||
| 12-1 Month Momentum % | -17.05 | ||
| 52-Week Range (Â¥) | 11.91 - 25.94 | ||
| Shares Outstanding (Mil) | 84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Dayang Biotech Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Dayang Biotech Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Dayang Biotech Group Co Ltd Frequently Asked Questions
What is Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017)'s stock price today?
The current price of SZSE:003017 is ¥20.67. The 52 week high of SZSE:003017 is ¥25.94 and 52 week low is ¥11.91.
When is next earnings date of Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017)?
The next earnings date of Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017) is .
Does Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017) is 4.11% (As of Today), Highest Dividend Payout Ratio of Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017) was 0.99. The lowest was 0.62. And the median was 0.63. The  Forward Dividend Yield % of Zhejiang Dayang Biotech Group Co Ltd(SZSE:003017) is 4.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers